We are live on ! Find out more
CCP

Corient Capital Partners Portfolio holdings

AUM $1.34B
1-Year Est. Return 12.46%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
-12.46%
3 Year Est. Return
+39.22%
5 Year Est. Return
+66.79%
10 Year Est. Return
AUM
$787M
AUM Growth
+$80.8M
Cap. Flow
+$26.5M
Cap. Flow %
3.37%
Top 10 Hldgs %
26.98%
Holding
498
New
39
Increased
268
Reduced
136
Closed
31

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$2.01M
2
MSFT icon
Microsoft
MSFT
+$1.78M
3
ETN icon
Eaton
ETN
+$1.18M
4
DHR icon
Danaher
DHR
+$1.12M
5
HBAN icon
Huntington Bancshares
HBAN
+$1.09M

Sector Composition

Rank Sector Weight
1 Technology 14.98%
2 Financials 12.65%
3 Healthcare 10.27%
4 Industrials 8.01%
5 Consumer Discretionary 7.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSCO icon
26
Cisco
CSCO
$448B
$5.95M 0.76%
123,962
+6,924
+6% +$322K
RTX icon
27
RTX Corp
RTX
$295B
$5.87M 0.75%
62,244
+4,649
+8% +$422K
NEE icon
28
NextEra Energy
NEE
$184B
$5.77M 0.73%
95,328
-3,276
-3% -$191K
SPY icon
29
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$5.69M 0.72%
17,681
+1,060
+6% +$326K
VZ icon
30
Verizon
VZ
$198B
$5.66M 0.72%
92,140
-3,838
-4% -$232K
PEP icon
31
PepsiCo
PEP
$191B
$5.29M 0.67%
38,671
+7,362
+24% +$1M
V icon
32
Visa
V
$690B
$5.08M 0.64%
27,008
+714
+3% +$129K
MRK icon
33
Merck
MRK
$324B
$4.9M 0.62%
56,470
+681
+1% +$55.9K
GOOG icon
34
Alphabet (Google) Class C
GOOG
$4T
$4.72M 0.6%
70,680
+1,620
+2% +$105K
D icon
35
Dominion Energy
D
$61.8B
$4.72M 0.6%
57,002
+1,233
+2% +$101K
XOM icon
36
ExxonMobil
XOM
$640B
$4.59M 0.58%
65,775
+1,465
+2% +$101K
IVW icon
37
iShares S&P 500 Growth ETF
IVW
$71.8B
$4.56M 0.58%
94,284
-3,116
-3% -$144K
PFE icon
38
Pfizer
PFE
$141B
$4.51M 0.57%
121,436
-2,073
-2% -$73.8K
TXN icon
39
Texas Instruments
TXN
$252B
$4.51M 0.57%
35,126
-28
-0.1% -$3.46K
ADBE icon
40
Adobe
ADBE
$95.4B
$4.42M 0.56%
13,415
+319
+2% +$93.9K
BLK icon
41
Blackrock
BLK
$163B
$4.41M 0.56%
8,770
+334
+4% +$158K
LLY icon
42
Eli Lilly
LLY
$1.07T
$4.15M 0.53%
31,565
+2,520
+9% +$292K
SBUX icon
43
Starbucks
SBUX
$119B
$4M 0.51%
45,534
+1,421
+3% +$121K
BAC icon
44
Bank of America
BAC
$435B
$3.95M 0.5%
112,173
+996
+0.9% +$32.2K
ABT icon
45
Abbott
ABT
$184B
$3.92M 0.5%
45,190
+1,356
+3% +$114K
APD icon
46
Air Products & Chemicals
APD
$65.2B
$3.92M 0.5%
16,696
+587
+4% +$132K
ACWI icon
47
iShares MSCI ACWI ETF
ACWI
$32.3B
$3.88M 0.49%
48,893
-5,492
-10% -$420K
DHR icon
48
Danaher
DHR
$137B
$3.85M 0.49%
28,277
+8,871
+46% +$1.12M
MA icon
49
Mastercard
MA
$488B
$3.83M 0.49%
12,842
+238
+2% +$67.1K
ABBV icon
50
AbbVie
ABBV
$458B
$3.73M 0.47%
42,144
+1,626
+4% +$135K

Similar funds

Corient Capital Partners's Q4 2019 Portfolio in Review

As of Q4 2019, Corient Capital Partners held 498 positions worth $787M, up 11% from $706M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Corient Capital Partners deployed $26.5M of net new capital in Q4 2019, opening 39 new positions and adding to 268 existing holdings. Its largest new stake was Huntington Bancshares: 74,119 shares worth $1.12M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Vanguard S&P 500 Growth ETF, an estimated $1.15M trimmed.

  • Corient Capital Partners's largest Q4 2019 buy was Huntington Bancshares: 74,119 shares worth $1.12M.
  • Corient Capital Partners added most to Bristol-Myers Squibb in Q4 2019, an estimated $2.01M increase.
  • Corient Capital Partners's biggest Q4 2019 reduction was Vanguard S&P 500 Growth ETF, cutting an estimated $1.15M.
  • Corient Capital Partners fully exited Celgene Corp in Q4 2019, selling an estimated $1.97M.
  • Corient Capital Partners's ten largest holdings make up 27% of its $787M portfolio in Q4 2019.
  • Corient Capital Partners opened 39 new positions and closed 31 in Q4 2019.
  • Corient Capital Partners's portfolio value rose 11% quarter-over-quarter to $787M.

Based on Corient Capital Partners's 13F filing for Q4 2019, filed 4 Feb 2020.